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Defect in apoptosis has been implicated as a major cause of resistance to chemotherapy observed in B cell
chronic lymphocytic leukaemia (B CLL). This study evaluated the pro-apoptotic effect of an
anthocyanin-rich dietary bilberry extract (Antho 50) on B CLL cells from 30 patients and on peripheral
blood mononuclear cells (PBMCs) from healthy subjects, and determined the underlying mechanism.
Antho 50 induced concentration- and time-dependent pro-apoptotic effects in B CLL cells but little or no
effect in PBMCs. Among the main phenolic compounds of the bilberry extract, delphinidin-3-O-glucoside
and delphinidin-3-O-rutinoside induced a pro-apoptotic effect. Antho 50-induced apoptosis is associated
with activation of caspase 3, down-regulation of UHRF1, a rapid dephosphorylation of Akt and Bad, and
down-regulation of Bcl-2. Antho 50 significantly induced PEG-catalase-sensitive formation of reactive
oxygen species in B CLL cells. PEG-catalase prevented the Antho 50-induced induction of apoptosis and
related signaling. The present findings indicate that Antho 50 exhibits strong pro-apoptotic activity through
redox-sensitive caspase 3 activation-related mechanism in B CLL cells involving dysregulation of the Bad/
Bcl-2 pathway. This activity of Antho 50 involves the glucoside and rutinoside derivatives of delphinidin.
They further suggest that Antho 50 has chemotherapeutic potential by targeting selectively B CLL cells.
C
hronic lymphocytic leukemia (CLL), defined by the accumulation of pathogenic B cells, is still an incurable
disease despite the recent development of novel therapeutic approaches. Dysregulation of apoptosis is a
hallmark of CLL making this disease an ideal experimental model of malignancy due to the failure of
apoptosis1. The current knowledge about themechanism responsible for dysregulation of apoptosis in CLL is still
poor. High levels of the anti-apoptotic protein Bcl-2 have been found in several hematological malignancies,
including CLL2,3. Therefore, overexpression of Bcl-2 has been suggested to have a central role in defects of
apoptosis and cell survival observed in CLL4. The opportunity to induce apoptosis by targeting Bcl-2 protein
and/or Bcl-2-regulating proteins such as Bad is therefore considered as a promising therapeutic approach inCLL5.
Several epidemiological studies have suggested that the consumption of fruits and vegetables can reduce the risk
of developing cancer. Polyphenol-rich products have been reported to have potential chemopreventive and
chemotherapeutic activities in cancer cells including CLL by targeting several apoptosis-regulating pathways6,7.
In this context, green tea and its active constituent epigallocatechin gallate (EGCG) have been shown to induce
apoptosis in leukemic B cells isolated from CLL patients8. At low concentrations, EGCG significantly increased
apoptosis in CLL cells involving Bcl-2 down-regulation, caspase 3 activation and the dephosphorylation of VEGF
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receptors8. Inhibition of the endogenous nitric oxide pathway caus-
ing caspase 3 activation during apoptosis has also been suggested to
contribute to the pro-apoptotic effects of polyphenolic compounds
such as derivatives of resveratrol and viniferin9.
Beneficial effects of berries have been reported in several diseases
such as cardiovascular diseases and cancer10,11. The protective and
anti-cancer effects of berries have been predominantly attributed to
their high content of polyphenolic compounds, especially anthocya-
nins10,11. Bilberry (Vacciniummyrtillus L.) is one of the richest dietary
natural sources of anthocyanins which has been shown to have sev-
eral therapeutic activities such as inhibition of angiogenesis and anti-
cancer properties10,12. Antho 50 is a bilberry extract composed of
about 50% of anthocyanins which has previously been shown to be
predominantly absorbed as glycosides from the stomach in rats13.
The aim of the present study was to evaluate the pro-apoptotic effects
of this bilberry extract rich in anthocyanins on CLL cells from 30
patients and peripheral blood mononuclear cells (PBMCs) from 5
healthy subjects and, if so, to determine the signaling pathway
involved.
Methods
Patients, cell separation, and culture conditions. All experiments were performed
in accordance with the Declaration of Helsinki and approved local ethical guidelines.
Patients received oral and written information on research and all signed a consent
form approved by the Ethic Committee (Comite´ de Protection des Personnes ‘‘Est-
IV’’, 1 place de l’Hoˆpital, 67091 Strasbourg Cedex, France). Cells were collected from
30 patients (21 male, 9 female) at the University Hospital of Strasbourg, France
(Table 1). Median age of the patients was 69 years (range: 43–83 years). Median
circulating lymphocytes count was 53.3 3 103/mL (range 4.2–190.2 3 103/mL).
Twenty-three patients were untreated for CLLwhile 7 had received 1 to 4 prior lines of
chemotherapy. All these 7 patients were off-therapy for at least two months at time of
cells sampling. Five peripheral blood samples have been sampled from donors and
used in the study. Disease has been characterized in all patients by increased
lymphocyte count in blood, typical cytological aspects of the cells and
immunophenotyping showing a monotypic cell population with a Matutes score of 4
or 5. Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll density-
gradient centrifugation (Lymphocyte Separation Medium, MP Biomedicals). Cells
were incubated at 1 to 2 3 106 cells/mL in RPMI 1640 medium containing 10% fetal
bovine serum and incubated at 37uC in an atmosphere of 5% CO2.
UPLC-PDA analysis. Bilberry anthocyanin purified extract, Antho 50, was kindly
provided by FERLUX S. A. (Cournon d’Auvergne, France). Standards of cyanidin-3-
O-gluoside, cyanidin-3-O-galactoside, cyanidin-3-O-rutinoside, delphinidin-3-O-
gluoside, delphinidin-3-O-galactoside and delphinidin-3-O-rutinoside were
purchased from Extrasynthese (Genay Cedex, France).
Antho 50 was hydrolyzed in acidic conditions as previously described14.
UPLC-PDA analysis of Antho 50 and the hydrolyzed extract was performed in a
liquid Acquity chromatograph (Waters) equipped with a photodiode array detector
(PDA). Separation was carried out at 50uC using an acquity BEH C18 column
(Merck), 100 mm 3 2.1 mm, filled with 1.7 mm particles. The elution gradient was
performed using water, acetonitrile and formic acid as solution: a linear gradient from
96% water to 75% in 10 min followed by a linear gradient from 75% to 96% water in
2 min; always with 2% formic acid. Flow rate was 0.2 mL/min. Absorbance was
recorded at 518 nm.
Measurement of total phenolic compounds and total anthocyanins.Total phenolic
content was determined according to the Folin-Ciocalteu method as previously
described15. The results were expressed in mg gallic acid equivalents (GAE) per gram
of extract. Total polyphenolic content was 513.20 6 16.20 mg GAE/g.
The determination of anthocyanin index was performed by the Ribereau-Gayon
method according to Gonza´lez-Rodrı´guez et al16. The results were expressed in mg
anthocyanins per gram of extract. The total anthocyanin content was of 450.31 6
5.70 mg/g.
Apoptosis analysis. The annexin V-FITC/PI apoptosis assay (BD Biosciences
Pharmingen, San Diego, CA, USA) was used to detect apoptosis. Experiments were
performed according to the manufacturer’s instructions on PBMCs and B cells from
CLL patients exposed to Antho 50 or to a pure anthocyanin at different
concentrations and for different times. Apoptosis rates were then assessed by flow
cytometry. At least 10,000 events were recorded and represented as dot plots.
Cell viability assay. Cells were seeded on 6-well plates at a density of 2 3 106 cells/
well, grown for 24 h and exposed to Antho 50 at 75 mg/mL for different times. Cell
viability ratio was determined by cell counting using the trypan blue exclusion
method (Invitrogen). The viability rate was obtained by dividing the number of
trypan blue-negative cells (viable cells) by the total number of cells.
Assessment of DNA fragmentation pattern. Genomic DNA was prepared
according to the manufacturer’s instructions (Qiagen, Courtaboeuf, France),
Table 1 | Clinical characteristics of the CLL patients
Patient no. Sex Age (y) Absolute lymphocytosis, 3103/mL Prior treatment status
1 F 60 54.9 Treated
2 M 81 84.4 Untreated
3 M 77 43.8 Untreated
4 M 70 190.2 Treated
5 M 76 80.0 Treated
6 M 64 101.2 Untreated
7 F 73 66.1 Treated
8 F 53 103.6 Untreated
9 M 68 6.9 Treated
10 M 70 45.5 Untreated
11 M 77 56.9 Untreated
12 M 75 11.6 Untreated
13 M 71 58.0 Untreated
14 F 71 4.2 Untreated
15 M 82 11.9 Untreated
16 M 73 14.2 Untreated
17 M 78 25.2 Untreated
18 F 67 18.9 Untreated
19 F 43 7.4 Untreated
20 M 61 17.8 Untreated
21 F 66 35.9 Treated
22 M 61 32.5 Untreated
23 M 81 9.5 Untreated
24 F 83 182.6 Untreated
25 M 56 68.4 Untreated
26 M 68 31.8 Treated
27 M 57 61.9 Untreated
28 M 79 30.3 Untreated
29 M 67 21.5 Untreated
30 F 66 122.5 Untreated
www.nature.com/scientificreports
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separated by electrophoresis on a 1% agarose gel and visualized under UV light with
ethidium bromide.
Western blot analysis. Cells were grown in 6-well plates and treated with different
concentrations of Antho 50 for different times. Cells were lysed with ice-cold RIPA
buffer (150 mM NaCl, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, 50 mM
Tris-HCl, pH 7.5, and a protease inhibitor mixture tablet). Equal amounts of total
proteins were separated on 10–12% polyacrylamide gel and electrophoretically
transferred to nitrocellulose membranes (GE Healthcare, Buckinghamshire, UK),
which were then blocked with 5% BSA (BioRad, Hercules, USA) for 1h30 at room
temperature. Membranes were then incubated with either a mouse monoclonal anti-
UHRF1 (Proteogenix, Oberhausbergen, France), a rabbit polyclonal anti-caspase 3, a
rabbit polyclonal anti-p-Bad, a rabbit polyclonal anti p-Akt Ser473 (Cell Signaling
Technology, Inc. Danvers, MA), a mouse monoclonal anti-p73 (BD Biosciences
Pharmingen), a mouse monoclonal anti-p53 (Santa Cruz Biotechnologies, Santa
Cruz, CA,USA), amousemonoclonal anti-Bcl-2 (Millipore, Darmstadt, Germany) or
a mouse monoclonal anti-b-tubulin or anti-b-actin antibody (Abcam, Paris, France),
according to the manufacturer’s instructions at 4uC overnight. The membranes were
then washed three times; 5 min/each time with PBS. Membranes were thereafter
incubated with the appropriate horseradish peroxidase-conjugated secondary
antibody (diluted to 1510,000 for anti-mouse antibody and 155,000 for anti-rabbit
antibody) at room temperature for 1 h. Membranes were then washed with PBS five
times. Signals were detected by chemiluminescence using an enhanced
chemiluminescence kit (GE Healthcare).
Determination of the cellular formation of reactive oxygen species. The oxidative
fluorescent dye dihydroethidium (DHE) was used to evaluate the formation of
reactive oxygen species (ROS). To determine the nature of ROS, cells were incubated
either with superoxide dismutase (SOD, 500 U/mL), catalase (500 U/mL), or PEG-
catalase (membrane permeant analog of catalase, 500 U/mL) for 30 min at 37uC.
Then, cells were challenged with or without Antho 50 (75 mg/mL) for different times
followed by the addition of DHE (5 mM) for 15 min. After staining with DHE, cells
were subjected to flow cytometry examination (BD FACSCalibur, Becton Dickinson,
Franklin Lakes, NJ, USA). Histograms of 10,000 events were recorded per
experiment.
Statistical Analysis. Results are presented as mean 6 SEM of at least three
independent experiments. In the case of pairwise between group comparisons,
statistical analysis was carried out using Student’s t test. Statistical analysis was also
performed using a two-way analysis of variance (ANOVA) followed by a Bonferroni
post-hoc test to compare differences. Significant differences are indicated as *P ,
0.05, **P , 0.001, ***P , 0.0001.
Results
Antho 50 selectively induces apoptosis in B CLL cells. To
determine whether Antho 50 induces apoptosis in CLL cells, the
detection of phosphatidylserine externalization by flow cytometry
using annexin V FITC/PI assay kit was performed. As indicated in
Fig. 1A, a concentration-dependent increase in annexin V positive
cells was observed in Antho 50-treated cells for 24 h and this effect
reached significance at concentrations greater than 25 mg/mL of
Antho 50. The percentage of annexin V positive cells reached
approximately 75% at 75 mg/mL. Incubation of cells with 75 mg/
mL of Antho 50 induced a time-dependent increase in annexin V
positive cells with a significant effect observed already at 1 h (Fig. 1B)
and which was associated with a reduction in cell viability (Fig. 1C).
To determine the selectivity of Antho 50, PBMCs from five healthy
adult donors were incubated with Antho 50 for 24 h (Fig. 1D).
Although Antho 50 at a concentration of 25 mg/mL significantly
induced apoptosis in CLL cells by about 50% (Fig. 1A), no such
Figure 1 | Antho 50 reduces cell viability and induces selectively a concentration- and time-dependent apoptosis in B CLL cells. Cells were exposed to
increasing concentrations of Antho 50 for 24 h or for 75 mg/mL for the indicated times. Apoptosis in B CLL cells (A, B) and in PBMCs (D) was assessed by flow
cytometry using the annexin V-FITC/PI apoptosis assay. Cell viability rate (C) was assessed by cell counting using the trypan blue dye exclusion assay. Equal
quantity of genomic DNA was analyzed on a 1% agarose gel. DNA was stained with ethidium bromide and then visualized under UV light (E). The control
(Ctr) represents untreated cells harvested at the latest time point. The data are representative of cells from nine CLL patients and four healthy subjects for
apoptosis, six CLL patients for cell viability and two for DNA fragmentation. Values are shown as means6 S.E.M. (n 5 3); *, P, 0.05, **, P, 0.01, ***, P,
0.001 versus respective control.
www.nature.com/scientificreports
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effect was observed in PBMCs (Fig. 1D). However, increasing the
concentration of Antho 50 to 75 mg/mL induced a slight but
significant apoptosis in PBMCs by about 36% (Fig. 1D). These
data indicate that Antho 50 is targeting predominantly neoplastic
B cells relative to PBMCs.
DNA fragmentation is a hallmark and also one of the later stages of
apoptosis. To confirm the apoptotic mechanism induced by Antho
50, DNA fragmentation analysis was conducted in cells of two CLL
patients. The intensity of the genomic DNA smears of the Antho 50-
treated CLL cells of both patients increased in a time-dependent
manner (Fig. 1E). Altogether, these findings indicate that Antho 50
selectively induces DNA damage-related apoptosis in B CLL cells.
Delphinidin glycosides induce apoptosis in B CLL cells. The
chemical analysis of Antho 50 bilberry extract indicated a
polyphenol rich composition (513.20 6 16.20 mg GAE/g) with a
major content of anthocyanins (450.31 6 5.70 mg/g). Talave´ra
et al. previously identified 15 major glycoside derivatives including
those of delphinidin, cyanidin, petunidin, peonidin and malvidin in
Antho 5013. In order to determine the proportion of the different
anthocyanidins, an UPLC-PDA analysis of the Antho 50 hydrolyzed
extract was performed. The Antho 50 content of delphinidin was
102.62 6 4.87 mg/g, cyanidin 91.05 6 3.95 mg/g, petunidin 75.99
6 3.93 mg/g, pelargonidin 1.32 6 0.05 mg/g, peonidin 9.51 6
0.44 mg/g and malvidin 84.31 6 4.73 mg/g. Furthermore, an
UPLC-PDA was performed to quantify anthocyanins in their
native forms. The Antho 50 content of delphinidin-3-O-rutinoside
was 89.17 6 1.67 mg/mg, delphinidin-3-O-glucoside 42.60 6
1.30 mg/mg, cyanidin-3-O-glucoside 2.36 6 0.10 mg/mg, petunidin-
3-O-glucoside 32.94 6 0.14 mg/mg and malvidin-3-O-glucoside
31.93 6 0.36 mg/mg.
In order to determine the pro-apoptotic activity of pure anthocya-
nins, B CLL cells were incubated for 24 h with 30 or 100 mM of six
commercially available anthocyanins: cyanidin-3-O-glucoside (1),
cyanidin-3-O-galactoside (2), cyanidin-3-O-rutinoside (3), delphini-
din-3-O-glucoside (4), delphinidin-3-O-galactoside (5) and delphi-
nidin-3-O-rutinoside (6) (Fig. 2A). Then, the level of apoptosis was
determined by flow cytometry. Treatment of B CLL cells with gluc-
oside and rutinoside delphinidin derivatives increased the percent-
age of apoptotic cells, whereas delphinidin-3-O-galactoside and the
cyanidin derivatives had only minor effects (Fig. 2B).
Antho 50 induces an early caspase 3 activation and UHRF1 down-
regulation in B CLL cells independently of the status of tumor
suppressor genes p53 and p73. Activation of caspase-dependent
cascade leading to apoptosis has been involved in polyphenolic
extracts-mediated cell death in cancer cells including leukaemia17–20.
We therefore determined the involvement of activated caspase 3, one of
the main executors of apoptosis in the pro-apoptotic effect of Antho 50
in CLL cells (Fig. 3). Exposure of cells to 75 mg/mL of Antho 50
induced a time-dependent caspase 3 activation (Fig. 3). A slight
increased expression of activated caspase 3 was observed already at
one h and thereafter the signal increased progressively at least until
6 h (Fig. 3).
UHRF1 (Ubiquitin-like containing PHD and ring finger domains
1), a potent oncogene overexpressed inmany human cancer cells, has
been shown to play an important role in the epigenetic silencing of
various tumor suppressor genes21–23. Several reports have indicated
that UHRF1 overexpression promotes proliferation of cancer cells by
inhibiting apoptosis suggesting that this oncogene is a new therapy
target for cancer cells, including leukaemia23–26. As shown in Fig. 3,
treatment of CLL cells with Antho 50 induced a decrease in UHRF1
expression accompanied by progressive activation of caspase 3 provid-
ing further evidence for the pro-apoptotic properties of Antho 50.
These results suggest that Antho 50-induced apoptosis is linked to a
rapid caspase 3 activation and UHRF1 down-regulation in CLL cells.
To characterize the Antho 50-induced pro-apoptotic signaling pathway
leading to caspase 3 activation, the levels of the tumor suppressor
proteins p53 and p73 were determined. As shown in Fig. 3, the levels
of p53 remained either unchanged or decreased in most CLL cells
samples (CLL1, CLL2, CLL4, and CLL11). In the samples isolated from
patients 3 and 5, an increase in p53 expression was observed at 6 h and
caspase 3 activation at 3 h (Fig. 3). The level of p73, a pro-apoptotic
member of the p53 family was undetectable or unchanged in 4 out of 6
CLL samples (Fig. 3). In the case of CLL 2, a pronounced increase in
the level of p73 was observed at 6 h and caspase 3 activation at 1 h, and
in the case of CLL 1, an increased level of p73 was observed in parallel
with caspase 3 activation (Fig. 3). Taken together, these results suggest
that the pro-apoptotic cellular response of CLL cells to Antho 50
involves caspase 3 activation and UHRF1 down-regulation predomi-
nantly via p53- and p73-independent pathways.
Antho 50 induces Bcl-2 down-regulation associatedwith Bad (Bcl-
2-associated death promoter) dephosphorylation.The Bcl-2 family
plays a key regulatory role in cellular responses to treatment via its
pro- and anti-apoptotic properties27. The anti-apoptotic protein Bcl-
2 is overexpressed in several hematological malignancies including
CLL and this overexpression is considered primarily responsible for
defective apoptosis in CLL28. We therefore evaluated the effect of
Antho 50 treatment on the expression of two major members of
the Bcl-2 family, Bcl-2 and p-Bad in cells from 3 CLL patients. As
shown in Fig. 4A, a reduced Bcl-2 level was observed in CLL cells as a
Figure 2 | Chemical structures of anthocyanins present in Antho 50 (A):
cyanidin-3-O-glucoside (1), cyanidin-3-O-galactoside (2), cyanidin-3-O-
rutinoside (3), delphinidin-3-O-glucoside (4), delphinidin-3-O-
galactoside (5) and delphinidin-3-O-rutinoside (6). B CLL cells were
exposed to 30 or 100 mM of the indicated anthocyanin for 24 h. Then
apoptosis rate was determined by flow cytometry using annexinV-FITC/PI
assay (B). The control (Ctr) represents untreated cells. The data are
representative of cells from four CLL patients. Values are shown as means
6 S.E.M. (n 5 4); ***, P , 0.001 versus control.
www.nature.com/scientificreports
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function of the treatment time with Antho 50. The down-regulation
of Bcl-2 was accompanied by a reduction of cell viability starting at
1 h (Fig. 4B).
Since the inactivation of p-Bad via its dephosphorylation induces
Bcl-2 down-regulation leading to apoptosis29, the state of p-Bad was
examined in response to Antho 50 treatment. Antho 50 treatment
induced an early pronounced dephosphorylation of Bad starting at
1 h, which was followed with the down-regulation of Bcl-2 (Fig. 4A).
Since p-Akt can phosphorylate Bad at Ser112 and Ser136 promoting
survival30, the potential of Antho 50 to inhibit the constitutive phos-
phorylation of Akt in CLL cells was examined. As indicated in Fig. 4A
Antho 50 caused dephosphorylation of Akt at Ser473 within 1 h.
These findings suggest that Antho 50 treatment causes dephosphor-
ylation of Akt at Ser473 leading to the subsequent dephosphorylation
of Bad, and ultimately the down-regulation of Bcl-2 producing
activation of the caspase 3-related apoptotic pathway.
Antho 50 induces apoptosis in CLL cells through generation of
ROS. Several in vitro and preclinical studies have shown that anti-
cancer drugs and natural products including polyphenols induce pro-
apoptotic effects in hematological cancer cells including CLL cells
through the generation of ROS18,19,31,32. Therefore experiments were
performed to determine whether Antho 50 stimulates the formation of
ROS in B CLL cells and, if so, it’s role in apoptosis. As indicated in
Fig. 5A, Antho 50 caused within 30 min a significant increase in the
formation of ROS in CLL cells as assessed using the redox-sensitive
probe DHE. To determine whether Antho 50-increased ROS
formation is an intracellular or an extracellular event, the effect of
various antioxidants was examined. Fig. 5B indicates that a marked
reduction of the formation of ROS was observed when Antho 50-
treated CLL cells were pre-incubated with the membrane-permeant
analog of catalase (PEG-catalase). In contrast neither native SOD nor
catalase had such an effect (Fig. 5B). Exposure of cells to the
intracellular antioxidant PEG-catalase significantly prevented the
Antho 50-induced reduction in cell viability (Fig. 5C) and apoptosis
(Fig. 5D) whereas native SOD and catalase had only slight effects.
Thus, these observations indicate that Antho 50 predominantly
stimulates the intracellular formation of ROS and that this effect is
an upstream event in the Antho 50-induced apoptosis.
Antho 50 affects apoptosis-regulating proteins in CLL cells
through a redox-sensitive mechanism. To determine whether the
intracellular formation of ROS is a key event in the Bad/Bcl-2
deregulation leading to activation of the caspase 3-related pro-
apoptotic signaling pathway in response to Antho 50, the effect of
various antioxidants were tested. Exposure of cells isolated from
patient 11, 26, 20 and 18 with PEG-catalase markedly reduced the
Antho 50-induced dephosphorylation of Bad and down-regulation
of Bcl-2 at 6 h (Fig. 6). Native SOD and catalase affected only slightly
or had no such effect on p-Bad and Bcl-2 (Fig. 6). The Antho 50-
induced activation of caspase 3 was inhibited in CLL cells CLL11, 6
and 20 (Fig. 7) and CLL9 and 10 (data not shown) in the presence of
PEG-catalase as well as the down-regulation of UHRF1 in CLL11, 6
and 20 (Fig. 7). In contrast, native SOD and catalase affected only
slightly or not at all both signals (Fig. 7). Altogether, these findings
indicate that Antho 50 triggers apoptosis in CLL cells through a
redox-sensitive activation of the caspase 3-related pro-apoptotic
pathway possibly through Bad dephosphorylation and Bcl-2 down-
regulation.
Discussion
Among hematological cancers, CLL is considered as a characteristic
example of a neoplasia caused by the failure of apoptosis4,33. Because
of the important chemotherapy resistance and drug toxicity observed
in treatment of this malignancy, there is a need for development of
new therapeutic approaches. The Bcl-2 family proteins have a central
Figure 3 | Antho 50 induces caspase 3 activation andUHRF1 down-regulation independently of p53 and p73. BCLL cells were incubated with Antho 50
at 75 mg/mL for the indicated times and thereafter the expression of the p53, p73, cleaved caspase 3 and UHRF1 was studied using Western blot. The
control (Ctr) represents untreated cells harvested at 6 h. The data are representative of cells from six CLL patients. Cleaved caspase 3 and UHRF1
expression levels were analyzed by densitometry and represented as percentage compared with control.
www.nature.com/scientificreports
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role in CLL cell survival and chemotherapy resistance1, making Bcl-2
inhibition as a potent target to induce apoptosis in CLL cells. The
present study indicates that a polyphenol-rich extract (Antho 50)
decreased cell viability and induced concentration- and time-depend-
ent apoptosis in cells isolated from CLL patients. Interestingly, Antho
50 had no or only a weak effect in PBMC isolated from healthy
subjects. The present study also sheds light onto the mechanism
underlying the Antho 50-induced apoptosis in B CLL cells.
Pharmacological inhibition of ROS formation indicated the involve-
ment of a redox-sensitive event in the caspase 3-related pathway in
Antho 50-induced apoptosis of B CLL cells. The present study is in
good agreement with recent reports indicating that anthocyanins
induce mainly a caspase 3-dependent apoptosis in cell lines derived
from colorectal cancer, and monocytic and promyelocytic hematolo-
gical malignancies30,34–37. The present findings extend these observa-
tions to the most frequent hematological malignancy, CLL, as
indicated by the observations with cells from 30 patients.
The present findings provide evidence for a molecular action of
Antho 50 in CLL involving activation of the caspase 3-related apop-
totic pathway, as a result of down-regulation of Bcl-2 subsequent to
Bad dephosphorylation. They further indicate that a rapid formation
of ROS is involved in Antho 50-induced apoptosis. It is well-known
that activation of Akt promotes cell survival by targeting several
proteins involved in the regulation of apoptosis such as the pro-
apoptotic Bcl-2 family member Bad30. The present findings indicate
that Antho 50-mediated rapid dephosphorylation of Akt is assoc-
iated with dephosphorylation of Bad protein at Ser112 and reduced
cell viability. It has been shown that the dephosphorylation of Bad
promotes cell death by interacting with the anti-apoptotic protein
Bcl-2 causing its down-regulation, which allows the activation of the
mitochondria-mediated pro-apoptotic pathway leading to caspase 3
activation and cell death38. Antho 50 rapidly induced Bad depho-
sphorylation in parallel with Bcl-2 down-regulation, caspase 3 activa-
tion and apoptosis. Previous reports have also indicated that
polyphenolic compounds such as resveratrol, quercetin, curcumin,
carnosic acid, and silibinin induced apoptosis via caspase 3 activation
in leukaemia cells17,39.
In addition, Antho 50 caused down-regulation of the epigenetic
integrator UHRF1, an anti-apoptotic protein which is overexpressed
in many human cancer cells and plays an important role in the
epigenetic silencing of various tumor suppressor genes including
p16INK4A, hMLH1 and RB121–23,40. The histone deacetylase (HDAC)
inhibitor valproate has been shown to act synergistically with fludar-
abine and cladribine, two clinically used anticancer drugs in the
Figure 4 | Antho 50 induces dephosphorylation of Akt at Ser473, Bad at Ser112 and down-regulation of Bcl-2 in B CLL cells.Cells were incubated with
Antho 50 at 75 mg/mL for the indicated times. The expression of the p-Akt, p-Bad and Bcl-2 was studied by Western blot (A, upper panel) and their
expression levels were analyzed by densitometry and represented as percentage compared with control (A, lower panel). Cell viability was assessed by cell
counting using the trypan blue dye exclusion assay (B). The control (Ctr) represents untreated cells harvested at 6 h. The data are representative of cells
from three CLL patients.
www.nature.com/scientificreports
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Figure 5 | Antho 50 decreases cell viability and triggers apoptosis in BCLL cells through generation of ROS.Cells were exposed to Antho 50 (75 mg/mL)
for different times (A) or to various inhibitors of ROS (B) for 30 min before the addition of Antho 50 (75 mg/mL) for 1 h. The formation of ROS was
assessed by flow cytometry after incubation with the redox-sensitive fluorescent probe DHE. Cells were incubated with various inhibitors of ROS for
30 min before the addition of Antho 50 (75 mg/mL) for 6 h for cell viability analysis (C) or for 24 h before the determination of apoptosis (D). The control
(Ctr) represents untreated cells harvested at 6 h. The data are representative of cells from three CLL patients for ROS analysis, three CLL patients for cell
viability, and four CLL patients for apoptosis analysis.
Figure 6 | Antho 50 affects p-Bad and Bcl-2 proteins through a ROS-dependent mechanism. B CLL cells were exposed to either PEG-catalase (500 U/
mL), catalase (500 U/mL), or SOD (500 U/mL) for 30 min before the addition of Antho 50 (75 mg/mL) for the indicated times. The expression of p-Bad
and Bcl-2 was studied usingWestern blot and their expression levels were analyzed by densitometry and represented as percentage compared with control
(Ctr). The control represents untreated cells harvested at the latest time point. The data are representative of four CLL patients.
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treatment of CLL cells41. Several reports have indicated that the anti-
cancer drugs-induced inhibition of UHRF1 activity and/or express-
ion might prevent the action of two of its preferred partners, namely
HDAC1 (histone deacetylase 1) and DNMT1 (DNA methyltrans-
ferases), leading to re-expression of several tumor suppressor genes
and thus allowing cancer cells to undergo apoptosis21,40,42. In agree-
ment with these observations, Antho 50 induced UHRF1 down-
regulation, such a response may lead to reduced HDAC1 activity
and as a consequence an increased apoptosis in CLL cells.
Altogether, these findings suggest that Antho 50 induces a combined
effect to kill CLL cells through caspase 3 activation and inhibition of
UHRF1-regulated expression of several proteins involved in the
repression of tumor suppressor genes.
Several reports have shown that polyphenolic compounds can
increase ROS levels in human cancer cells, including leukemia and
that this response is involved in the pro-apoptotic effect of red wine
polyphenols, Aronia melanocarpa polyphenols and EGCG through
UHRF1 down-regulation and caspase 3 activation in leukemia
cells18,19. Similarly, in the present study Antho 50 treatment of CLL
cells rapidly induced an increased formation of ROS causing a reduc-
tion in cell viability and induction of apoptosis. The intracellular
antioxidant PEG-catalase prevented the Antho 50-induced forma-
tion of ROS, reduction of cell viability and induction of apoptosis
indicating a determinant role of ROS. In addition, the antioxidant
PEG-catalase inhibited also the Antho 50-induced Bad dephosphor-
ylation, Bcl-2 and UHRF1 down-regulation and caspase 3 activation
providing further evidence that ROS play a key role in the Antho 50-
induced apoptosis in CLL cells.
Polyphenols, particularly anthocyanins, have been reported to
mediate the pro-apoptotic properties of different berries in various
Figure 7 | Antho 50 affects cleaved caspase 3 and UHRF1 proteins through a ROS-dependent mechanism. B CLL cells were exposed to either PEG-
catalase (500 U/mL), catalase (500 U/mL), or SOD (500 U/mL) for 30 min before the addition of Antho 50 (75 mg/mL) for the indicated times. The
expression of cleaved caspase 3 and UHRF1 was studied usingWestern blot and their expression levels were analyzed by densitometry and represented as
percentage compared with control (Ctr). The control represents untreated cells harvested at 6 h. The data are representative of three CLL patients.
Figure 8 | Schematic summarizing the pro-apoptotic signaling cascade in
B CLL cells induced by Antho 50.
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types of cancer cells, including those from colon tumors and leuke-
mia19,43,44. Our findings have identified the glucoside and rutinoside
derivatives of delphinidin as active components of Antho 50 involved
in the induction of apoptosis. Katsube et al. also observed that del-
phinidin strongly inhibited the growth of HL60 human promyelo-
cytic leukemia cells whereas cyanidin had little effect45. Altogether,
these observations suggest that a hydroxyl group on position 59 of the
B ring is a key structural characteristic involved in B CLL cytotoxi-
city. Since Antho 50 is a complexmixture of phytochemicals, and the
pro-apoptotic effect of the extract is superior to that attributable to
two major anthocyanins (delphinidin-3-O-glucoside and delphini-
din-3-O-rutinoside) of Antho 50, anthocyanins and possibly also
other polyphenols, as flavonols and chlorogenic acid, might act in
synergy to induce apoptosis in B CLL cells46,47.
In conclusion, the present study highlights the potential of Antho
50 to induce a redox-sensitive apoptosis in CLL cells with little effect
on healthy PBMC.Delphinidin-3-O-glucoside and delphinidin-3-O-
rutinoside were identified as active anthocyanins. It further suggests
that Bcl-2 which is known to protect CLL cells from apoptosis, is a
major target for Antho 50 and that its degradation via Bad depho-
sphorylation leads to caspase 3 activation (Fig. 8).
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